Garry Blakely Awarded $100,000 for Novel Oral Vaccine

Bacterial Nano-Particles as Oral Vaccines Against Diarrhoea
Garry Blakely of the University of Edinburgh has been awarded $100,000 by the Bill and Melinda Gates Foundation to develop a novel oral vaccination strategy against diarrhoeal diseases which are endemic in the Third World. The project will use a synthetic biology approach, in combination with a bacterium normally found in the human gut, to develop biocompatible delivery vehicles as oral vaccines.
 

Story tags: 

Please tell us what you think about this website !

What do you think of the Edinburgh Infectious Diseases website?  We would be very grateful if you could spare 2 minutes to help us improve the useability and look of our pages. Thank you for your help !